Divya Pushkarna, B.Tech

Research Manager

Divya’s expertise primarily lies within the Health Economics and Outcomes Research (HEOR) and market access domains. Divya’s project portfolio encompasses a wide range of areas including epidemiology, clinical burden, clinical efficacy, safety, and effectiveness, as well as humanistic and economic burden. Her work focuses on supporting health technology assessment submissions and dossiers, delivering valuable insights to clients. With a proactive approach, unwavering diligence, and profound expertise, Divya plays a crucial role in ensuring high-quality deliverables for clients and steering the team’s growth in the right direction. Prior to her joining the team at Evidinno, Divya held key roles at Syneos Health (Kinapse) and IQVIA. In these capacities, she led multiple systematic literature review projects and worked on pricing and market access initiatives. At Syneos Health, she also served as a senior consultant, overseeing the external reference pricing team for mid-sized pharmaceutical companies. Divya’s contributions to the field are further exemplified by her co-authorship of multiple publications in the HEOR and market access domains. With Divya’s extensive experience, collaborative approach, and aptitude for delivering impactful outcomes, Evidinno benefits from her valuable contributions as a Research Manager, ensuring the team’s success and the provision of high-quality services to clients. Divya holds a Bachelor of Technology (B.Tech) degree in biotechnology from India.

Interests/hobbies: Sports, spending time with family and friends, reading books, and listening to music

Michael del Aguila

Michael del Aguila comes to Evidinno with 25 years experience in consulting and work inside Life Sciences companies in support of market access and real world evidence generation.  This includes executive positions at Roche, Genentech, Bristol-Myers Squibb and Gilead. 

In BioPharma Michael led teams responsible for sponsored real world evidence and HEOR clinical and observational studies, as well as market access and pricing. His executive leadership in consulting services has included those same domains.

He is pleased to have the opportunity to lead Evidinno’s expansion in product offerings and customer base as we continue our growth trajectory. 

Interests/hobbies: Theater, live music, hiking and running

Jean Paul Collet

Jean-Paul is the Chief Scientific Officer at Evidinno. JP is a trained pediatrician with MSc in Health Economics and PhD in Epidemiology from McGill University. He’s been a Professor and Associate Head Research in the Department of Pediatrics at UBC since 2006. JP’s career in clinical research has been associated with receiving many competing grants (over $30 million), the supervision of over 50 students completing MSc, PhD or Postdoc, and numerous publications (200+) with many of them related to drug evaluation methodology, economic impact and outcomes research.

Interests/hobbies: Practicing Tai Chi and Hiking; Holistic approach for self-development; Philosophy

Masoud Pourrahmat

Masoud Pourrahmat acts as the Head of Operations at Evidinno. With a career spanning over a decade, he possesses extensive expertise in the field of HEOR. Masoud has demonstrated exceptional competence in overseeing and executing targeted or systematic literature reviews, meta-analyses, network meta-analyses, and surrogacy analyses of clinical outcomes. His contributions have encompassed diverse areas such as oncology, neurology, cardiology, endocrinology, immunology, and digital health, among others.

Interests/hobbies: Reading, history, cooking.

Mir Sohail Fazeli

Dr. Mir Sohail Fazeli is the President and Managing Director at Evidinno Outcomes Research Inc. He has over two decades of experience working within academia and industry acting as the principal investigator, project lead, and medical research consultant. His work in evidence synthesis covers a diverse range of methodologies, including systematic and targeted literature reviews of clinical trials and observational studies, meta-analyses, network meta-analyses, and complex statistical modelling studies.